PRIMARY STUDY
Cannabis and Canabidinoids on the Inflammatory Bowel Diseases: Going Beyond Misuse
Key Findings: The antioxidant and anti-inflammatory effects of cannabis or cannabinoid-based therapeutics may improve ulcerative colitis and Crohn's Disease but more clinical trials are needed to establish clinical treatment criteria.
Type of Study: Meta-analysis
Study Result: Positive
Research Location(s): Brazil
Year of Pub: 2020
Cannabinoids Studied: Cannabidiol (CBD), Tetrahydrocannabinol (THC), Cannabinoid (unspecified)
Phytocannabinoid Source: Unspecified
Citation: Carvalho ACA, et al. Cannabis and Canabidinoids on the Inflammatory Bowel Diseases: Going Beyond Misuse. Int J Mol Sci. 2020; 21:(unknown pages). doi: 10.3390/ijms21082940
Authors: Carvalho ACA, Souza GA, Marqui SV, Guiguer ÉL, Araújo AC, Rubira CJ, Goulart RA, Flato UAP, Bueno PCDS, Buchaim RL, Barbalho SM
